140 related articles for article (PubMed ID: 20145077)
1. Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice.
Rodríguez MM; Pastor FJ; Sutton DA; Calvo E; Fothergill AW; Salas V; Rinaldi MG; Guarro J
Antimicrob Agents Chemother; 2010 May; 54(5):1665-9. PubMed ID: 20145077
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
Salas V; Pastor FJ; Calvo E; Alvarez E; Sutton DA; Mayayo E; Fothergill AW; Rinaldi MG; Guarro J
Antimicrob Agents Chemother; 2012 May; 56(5):2246-50. PubMed ID: 22290952
[TBL] [Abstract][Full Text] [Related]
3. Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Rodríguez MM; Pastor FJ; Calvo E; Salas V; Sutton DA; Guarro J
Antimicrob Agents Chemother; 2009 Dec; 53(12):5022-5. PubMed ID: 19786601
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis.
Lewis RE; Ben-Ami R; Best L; Albert N; Walsh TJ; Kontoyiannis DP
J Infect Dis; 2013 Mar; 207(5):834-41. PubMed ID: 23242544
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
Spreghini E; Orlando F; Giannini D; Barchiesi F
J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Arikan S; Sancak B; Alp S; Hascelik G; McNicholas P
Med Mycol; 2008 Sep; 46(6):567-73. PubMed ID: 19180726
[TBL] [Abstract][Full Text] [Related]
7. Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
Salas V; Pastor FJ; Calvo E; Sutton D; García-Hermoso D; Mayayo E; Dromer F; Fothergill A; Alvarez E; Guarro J
Med Mycol; 2012 Oct; 50(7):710-5. PubMed ID: 22458251
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity and in vivo efficacy of posaconazole in treatment of murine infections by different isolates of the Aspergillus terreus complex.
Salas V; Pastor FJ; Rodríguez MM; Calvo E; Mayayo E; Guarro J
Antimicrob Agents Chemother; 2011 Feb; 55(2):676-9. PubMed ID: 21115792
[TBL] [Abstract][Full Text] [Related]
9. Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
Bellanger AP; Albert ND; Lewis RE; Walsh TJ; Kontoyiannis DP
Antimicrob Agents Chemother; 2015 Dec; 59(12):7830-2. PubMed ID: 26392499
[TBL] [Abstract][Full Text] [Related]
10. Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin B.
Gebremariam T; Alkhazraji S; Gu Y; Najvar LK; Borroto-Esoda K; Patterson TF; Filler SG; Wiederhold NP; Ibrahim AS
Antimicrob Agents Chemother; 2024 May; 68(5):e0154523. PubMed ID: 38557112
[TBL] [Abstract][Full Text] [Related]
11. Posaconazole prophylaxis in experimental systemic zygomycosis.
Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Pisa E; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2007 Jan; 51(1):73-7. PubMed ID: 17060525
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Posaconazole against Rhizopus oryzae Infection in Silkworm.
Kurakado S; Matsumoto Y; Sugita T
Med Mycol J; 2021; 62(3):53-57. PubMed ID: 34471035
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.
Lewis RE; Albert ND; Liao G; Hou J; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2010 Mar; 54(3):1298-304. PubMed ID: 20038620
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.
Espinel-Ingroff A
J Clin Microbiol; 2006 Oct; 44(10):3616-22. PubMed ID: 16943356
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
Lewis RE; Liao G; Wang W; Prince RA; Kontoyiannis DP
Virulence; 2011; 2(4):348-55. PubMed ID: 21788730
[TBL] [Abstract][Full Text] [Related]
16. Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.
Bellanger AP; Tatara AM; Shirazi F; Gebremariam T; Albert ND; Lewis RE; Ibrahim AS; Kontoyiannis DP
J Infect Dis; 2016 Jul; 214(1):114-21. PubMed ID: 26984141
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model.
Saoulidis S; Simitsopoulou M; Dalakiouridou M; Walsh TJ; Wheat LJ; Papaioannidou P; Roilides E
Mycoses; 2011 Sep; 54(5):e486-92. PubMed ID: 21039940
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.
Gebremariam T; Alkhazraji S; Lin L; Wiederhold NP; Garvey EP; Hoekstra WJ; Schotzinger RJ; Patterson TF; Filler SG; Ibrahim AS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652241
[TBL] [Abstract][Full Text] [Related]
19. Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae.
Rodríguez MM; Serena C; Mariné M; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2008 Oct; 52(10):3786-8. PubMed ID: 18694953
[TBL] [Abstract][Full Text] [Related]
20. Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
Spreghini E; Maida CM; Tomassetti S; Orlando F; Giannini D; Milici ME; Scalise G; Barchiesi F
Antimicrob Agents Chemother; 2008 Jun; 52(6):1929-33. PubMed ID: 18391037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
